Phibro Animal Health | PAHC - Current Assets


Phibro Animal Health reported $894.07M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Align Technology USD 2.66B 38.87M Mar/2026
ANI Pharmaceuticals USD 747.08M 6.03M Mar/2026
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bristol-Myers Squibb USD 27.21B 2.18B Mar/2026
Canopy Growth CAD 524.67M 78.85M Dec/2025
Corcept Therapeutics USD 426.03M 59.43M Mar/2026
Eli Lilly USD 54.84B 794M Mar/2026
Henry Schein USD 4.5B 32M Mar/2026
Idexx Laboratories USD 1.45B 40.25M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Merck USD 35.02B 8.5B Mar/2026
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Pacira USD 514.96M 33.01M Mar/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Prestige Brands USD 431.48M 1.94M Mar/2026
Supernus Pharmaceuticals USD 731.58M 87.4M Mar/2026
Zoetis USD 6.47B 294M Mar/2026